H HAWAII BIOTECH
Live / Registered — Registered (as of 16 May 2023)
What this means for you
Registered since 16 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90336899
- Registration number
- 7055935
- Mark type
- Design + words
- Filed
- 23 Nov 2020
- Published for opposition
- 08 Feb 2022
- Registered
- 16 May 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of eliminating toxins and inflamatory, infectious, and neurological diseases, disorders and conditions; therapeutic pharmaceuticals for the treatment of inflamatory, infectious, and neurological diseases, disorders and conditions; vaccines; proteins, namely, recombinant sub-unit proteins for diagnosing medical conditions, protein arrays for medical diagnosing, and protein arrays for medical diagnosis purposes
- Class 040 — Treatment of materials: Custom manufacture for others of proteins used for medical purposes
- Class 042 — Scientific and technological services: Medical and scientific research and development in the fields of immunology, oncology, epidemiology, and infectious diseases; medical and scientific research and development of pharmaceuticals, vaccines, and therapeutics
Owner
- Hawaii Biotech, Inc., Honolulu, HI, US
- Hawaii Biotech, Inc., Honolulu, HI, US
- Hawaii Biotech, Inc., Honolulu, HI, US
Prosecution history
- 16 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Mar 2023 — USE AMENDMENT FILED
- 05 Apr 2023 — SOU EXTENSION 2 GRANTED
- 27 Mar 2023 — SOU EXTENSION 2 FILED
- 04 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2022 — SOU EXTENSION 1 GRANTED
- 08 Sept 2022 — SOU EXTENSION 1 FILED